NOI HT941026N0101 Ipack Unit Dose System.docx

Notice of Intent to Sole Source HT941026N0101

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE PURCHASE ORDER CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD-W), Echo Branch intends to negotiate and award a firm-fixed price purchase order (PO) contract for the provision of all services, materials, and equipment necessary to provide required iPack Rx Unit Dose Packaging System to include Annual Premium Customer Support for Naval Hospital Camp Pendleton in accordance with Federal Acquisition Regulation (FAR) 6.302-1 Sole Source acquisitions and FAR 12.102 (a) only one source being available to meet the Government’s needs, to:

Pearson Medical Technologies LLC 2804 N Bolton Ave, Alexandria LA 71303-4509.

UEI: PCRNGWJC3NP8

CAGE: 8A7G3

The North American Industry Classification System (NAICS) code for this requirement is 333993 – Packaging Machinery Manufacturing; the business size standard is 600 (# of employees). The Product Service Code (PSC) is 6515 - Medical and surgical instruments, equipment, and supplies The requirement is for iPack Rx Unit Dose Packaging System to include Annual Premium Customer Support contract for Naval Hospital Camp Pendleton. The iPack Rx Unit Dose Packaging System (manufactured by Pearson Medical Technologies) is a cutting-edge, tabletop pharmacy automation system designed to streamline oral solid medication packaging into individual unit doses. It is widely used in acute care hospitals, centralized repackaging facilities, and institutional pharmacies to increase medication safety and operational efficiency. This procurement will replace an End-of-Life (EOL) legacy iPack system currently in place with the new iPack Rx Unit Dose Packaging System

Requirement

Delivery Location:

Naval Hospital Camp Pendleton Bldg. H135 Marine Corp Base M/F: Pharmacy Department Camp Pendleton, CA 92055-5191

Delivery:

On or before: 9/30/2026

Based on market research and previous acquisition history, it has been determined that Pearson Medical Technologies LLC is the only source that can meet the Government’s specialized requirement.

This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.

If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Denise Bond at denise.d.bond.civ@health.mil and Mariangela Monsalve at mariangela.j.monsalve.civ@health.mil . The closing date for challenges is no later than 10:00 a.m. (Pacific), 25 August 2026.

NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.